Highlights and Announcements

Today, the National Institute of Neurological Disorders and Stroke (NINDS) announced the selection of Michelle Jones-London, Ph.D., as the Institute’s first Associate Director for Programs to Enhance the Neuroscience Workforce.

The National Institutes of Health Stroke Scale (NIHSS), or NIH Stroke Scale, is the most widely used tool for health professionals to assess the severity of a stroke. Developed more than 30 years ago, the NIH Stroke Scale has recently been updated with new visual stimuli and is available for download.

The National Institutes of Health (NIH) has selected 10 recipients of the NIH Institutional Excellence in Diversity, Equity, Inclusion, and Accessibility (DEIA) in Biomedical and Behavioral Research Prize. Among the awardees—each receiving $100,000—is the University of Puerto Rico-Rio Piedras (UPR-RP) in recognition of their Neuroscience Research Opportunities to Increase Diversity (NeuroID) program.

Team science expands our ability to pursue some of the most challenging problems in neuroscience in a comprehensive, multidisciplinary, and mechanistic manner. The National Institute of Neurological Disorders and Stroke (NINDS) announces the first round of awards for the new NINDS Collaborative Opportunities for Multidisciplinary, Bold, and Innovative Neuroscience (COMBINE) program.

ReveraGen BioPharma, a company supported by a small business grant from the National Institute of Neurological Disorders and Stroke (NINDS), has developed a new drug for Duchenne muscular dystrophy (DMD), a genetic muscle-wasting disease.

The National Institutes of Health is committed to advancing research on amyotrophic lateral sclerosis (ALS).

In the human brain, 86 billion neurons form more than 100 trillion connections with other neurons at junctions called synapses. Scientists are now working on an ambitious effort to develop technologies to map these connections across the brain, from mice to humans.

Today, the National Institute of Neurological Disorders and Stroke (NINDS) announced the selection of neuroscientist Jeffrey S. Diamond, Ph.D., as Scientific Director.

Dr. Michael Oshinsky, Director of the NINDS Office of Preclinical Pain Research, is the featured guest on the July 27 episode of the Spotlight on Migraine podcast, “Understanding and Managing Migraine in Kids and Teens.”